1 minute read

Public Health Dr. Samah Hayek

Leveraging big data to improve public health and cancer care

We are in a new era of medicine and healthcare where innovation and big data are a significant part of healthcare delivery Cancer care does not only rely on advanced and therapeutic solutions, but it starts years before cancer diagnosis. Further, cancer care does not end with the completion of cancer therapy, it continues decades after therapy. Thus, there is a need for establishing innovative approaches and new clinical decision tools to assist in the early identification of individuals at most risk of developing.

Dr. Samah Hayek, DrPH, is a faculty member in the Department of Epidemiology and Preventive Medicine, at the School of Public Health, Faculty of Medicine. She also serves as a senior researcher/ Epidemiologist at Clalit Research Institute.Samah holds a B.A. in statistics, and sociology-anthropology; and a Master Degree in public heath from the University of Haifa. She obtained her doctoral degree in Public Health (Epidemiology) at the University of Kentucky, as a Fulbright scholar. She completed a twoyear fellowship at the Center for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. Further, she completed a post-doctoral study in the department of Epidemiology and Cancer Control, at St. Jude Children Research Hospital, Memphis, Tennessee, USA.

cancer, based on the combination of genotype and phenotype data. Dr. Hayek’s studies explore the late effect of cancer therapies among children, adolescents, and young adult cancer survivors. She has been utilizing big data from large national and international cohorts and using electronic medical record data to answer the unmet medical need of clinicians and patients

This article is from: